Promotion of liver regeneration and intrahepatic metastasis of hepatocellular carcinoma by Histone acetylation
组蛋白乙酰化促进肝细胞癌肝再生及肝内转移
基本信息
- 批准号:14370392
- 负责人:
- 金额:$ 8.96万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
【Aim】The aim of this study was to clarify the effect of histone acetylation on invasion, metastasis as well as differentiation of hepatocellular carcinoma (HCC). In addition, we evaluated the role of histone acetylation during liver regeneration.【Methods and results】(1)The role of histone deacetylase 1 (HDAC1) expression in HCC : High expression of HDAC1 was correlated with proliferation and invasion of HCC, and patients with increased expression of HDAC1 exhibited a poor prognosis.(2)The effect of HDAC inhibition on liver regeneration : Administration of HDAC inhibitor, Trichostatin A (TSA), followed by 70% of hepatectomy in rats, accelerated liver generation (higher values of BrdU labeling index and mitosis index). The expression of hepatocyte-specific genes was not down-regulated in the early phase regeneration.(3)Effect of HDAC inhibition on metastasis and differentiation of HCC, and liver regeneration : TSA redeuced the expression of HDAC and inhibited the proliferation of human H … More CC cell lines (HepG2 and HuH7). Inversely, TSA induced the differentiation of HCC cell lines. cDNA microarray revealed that some hepatocyte-specific genes were upregulated in TSA-treated cells. Administration of TSA followed by 70% of hepatectomy and intrasplenic administration of hepatoma cells reduced the number of liver metastases in rats.(4)Effect of HDAC antisense induction : Induction of HDAC1 antisense to human HCC cell line decreased the expression of HDAC1 and inhibited cell proliferation. In addition, induction of HDAC1 antisense accelerated albumin synthesis (differentiation of HCC cell lines).(5)HDAC inhibition and COX-II : Gamma linoleic acid (GLA) decreased cell viability of HCC cell lines and altered the gene expression associated with cell cycle. In addition, GLA decreased COX-II-expression and altered the constitution of fatty acid in the liver tissues. In rats, GLA accelerated liver regeneration after 70% hepatectomy, and inhibited tumor growth in the subcutaneous tumor model.【Conclusion】Inhibition of histone deacetylation accelerated liver regeneration after hepatectomy and hepatocyte-specific function during regeneration. In addition, the inhibition of HDAC promoted and differentiation of HCC cell lines and inhibited metastasis of HCC cells. Those results suggest that control of histone acetylation should be a new target for liver regeneration and HCC. Less
[目的]探讨组蛋白乙酰化对肝细胞癌(HCC)侵袭、转移及分化的影响。此外,我们评估了组蛋白乙酰化在肝再生过程中的作用。[方法与结果](1)组蛋白去乙酰化酶1(HDAC 1)在肝癌中的作用:HDAC 1的高表达与肝癌的增殖和侵袭性有关,HDAC 1高表达者预后差。(2)HDAC抑制剂对肝再生的影响:给予HDAC抑制剂曲古抑菌素A(TSA)后,大鼠肝切除70%,肝再生速度加快(BrdU标记指数和有丝分裂指数升高)。肝细胞特异性基因的表达在再生早期没有下调。(3)抑制HDAC对肝癌转移、分化及肝再生的影响:TSA可降低HDAC的表达,抑制人肝癌细胞的增殖。 ...更多信息 CC细胞系(HepG 2和HuH 7)。TSA对肝癌细胞系有诱导分化作用。cDNA微阵列显示TSA处理的细胞中一些肝细胞特异性基因表达上调。TSA的管理,然后是70%的肝切除术和脾内肝癌细胞的管理减少了大鼠肝转移的数量。(4)HDAC反义诱导的作用:HDAC 1反义诱导人肝癌细胞株HDAC 1表达降低,细胞增殖受到抑制。此外,HDAC 1反义的诱导加速了白蛋白的合成(HCC细胞系的分化)。(5)HDAC抑制和COX-Ⅱ:γ-亚油酸(GLA)降低HCC细胞系的细胞活力,改变与细胞周期相关的基因表达。此外,GLA降低COX-Ⅱ表达,改变肝组织脂肪酸组成。在大鼠中,GLA加速70%肝切除术后的肝再生,并抑制皮下肿瘤模型中的肿瘤生长。[结论]抑制组蛋白去乙酰化可促进肝切除后肝再生,并促进再生过程中肝细胞的特异性功能。抑制HDAC可促进肝癌细胞的分化,抑制肝癌细胞的转移。这些结果表明,控制组蛋白乙酰化应该是肝再生和HCC的新靶点。少
项目成果
期刊论文数量(60)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma
- DOI:10.1136/jcp.56.11.854
- 发表时间:2003-11-01
- 期刊:
- 影响因子:3.4
- 作者:Sugimachi, K;Tanaka, S;Tsuneyoshi, M
- 通讯作者:Tsuneyoshi, M
The role of heat shock protein 27 expression in hepatocellular carcinoma in Japan: special reference to the difference between hepatitis B and C
- DOI:10.1111/j.1478-3231.2004.0927.x
- 发表时间:2004-08-01
- 期刊:
- 影响因子:6.7
- 作者:Harimoto, N;Shimada, M;Maehara, Y
- 通讯作者:Maehara, Y
Effect of dietary conjugated linoleic acid on liver regeneration after a partial hepatectomy in rats
- DOI:10.3177/jnsv.50.9
- 发表时间:2004-02-01
- 期刊:
- 影响因子:1.6
- 作者:Hirao, A;Yamasaki, M;Yamada, K
- 通讯作者:Yamada, K
Shinji Itoh, et al.: "Role of Expression of Focal Adhesion Kinase on Progression in Hepatocellular Carcinoma"Clinical Cancer Research. (in press).
Shinji Itoh 等人:“粘着斑激酶表达对肝细胞癌进展的作用”临床癌症研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Muscle-targeted interleukin-12 gene therapy of orthotopic hepatocellular carcin oma in mice using in vivo electrosonoporation
使用体内电声穿孔法对小鼠原位肝细胞癌进行肌肉靶向白细胞介素 12 基因治疗
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Yamashita Y;et al.
- 通讯作者:et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHIMADA Mitsuo其他文献
SHIMADA Mitsuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHIMADA Mitsuo', 18)}}的其他基金
Development of integrated treatment for impaired liver regeneration on non-alcoholic steatohepatitis
非酒精性脂肪性肝炎肝再生受损综合治疗的进展
- 批准号:
18H02871 - 财政年份:2018
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of multidisciplinary therapy for aged liver insufficiency based on the mechanism of hepatic stellate cell dysfunction.
基于肝星状细胞功能障碍机制发展老年肝功能不全的多学科治疗。
- 批准号:
26293288 - 财政年份:2014
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The possible mechanism on homing effect of adipose-derived stem cells to the injured liver
脂肪干细胞对受损肝脏归巢作用的可能机制
- 批准号:
24659611 - 财政年份:2012
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of multidisciplinary therapy based on mechanism of liver insufficiency in a use of Aged partial graft after liver transplantation.
基于肝功能不全机制的多学科治疗在肝移植术后使用老年部分移植物中的发展。
- 批准号:
23390324 - 财政年份:2011
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The study to clarify a mechanism of replacing growth of the hepatocellular carcinoma using the adipose tissue derived stem cells
阐明利用脂肪组织来源的干细胞替代肝细胞癌生长的机制的研究
- 批准号:
22659243 - 财政年份:2010
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
脂肪肝グラフト部分肝移植における機能不全の解明と統合的治療法の開発
脂肪肝部分肝移植功能障碍的阐明及综合治疗方法的开发
- 批准号:
20390359 - 财政年份:2008
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The strategies for overcoming the graft dysfunction after liver transplantation using small-for-size graft
克服小体积肝移植术后移植物功能障碍的策略
- 批准号:
17390370 - 财政年份:2005
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a super liver graft resistant to various kinds of injuries by a gene-transfer technique
通过基因转移技术开发出抗各种损伤的超级肝移植物
- 批准号:
13357011 - 财政年份:2001
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
相似海外基金
Senolytic trial for Aged Liver Regeneration Failure
老年肝脏再生失败的 Senolytic 试验
- 批准号:
23K19457 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
The role of liver progenitor cells in liver regeneration
肝祖细胞在肝再生中的作用
- 批准号:
10607301 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Promoting in vitro propagation of primary human hepatocytes as organoids using cues from natural liver regeneration
利用自然肝再生的线索促进原代人肝细胞作为类器官的体外增殖
- 批准号:
471981 - 财政年份:2022
- 资助金额:
$ 8.96万 - 项目类别:
Fellowship Programs
A new role of pancreatic growth-related factors (REG3) in two-staged rapid liver regeneration
胰腺生长相关因子(REG3)在两阶段快速肝再生中的新作用
- 批准号:
22K08817 - 财政年份:2022
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration
VEGFA 在利用胆管细胞驱动的肝再生中的作用的研究
- 批准号:
10631156 - 财政年份:2022
- 资助金额:
$ 8.96万 - 项目类别:
Restoration and preservation of hepatic cardiolipin levels promotes liver regeneration in AH
肝心磷脂水平的恢复和保存促进 AH 中的肝再生
- 批准号:
10708057 - 财政年份:2022
- 资助金额:
$ 8.96万 - 项目类别:
The cell identification research of bone marrow drived liver repaired cell in the new liver regeneration therapy
新型肝再生疗法中骨髓驱动的肝修复细胞的细胞鉴定研究
- 批准号:
22K08057 - 财政年份:2022
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
de novo approach to liver regeneration and liver disease focusing on PUFA containing phospholipids
以含有磷脂的 PUFA 为重点的肝再生和肝病从头方法
- 批准号:
22K08788 - 财政年份:2022
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Do Revival Stem Cells Contribute to Liver Regeneration?
复兴干细胞有助于肝脏再生吗?
- 批准号:
RGPIN-2020-07168 - 财政年份:2022
- 资助金额:
$ 8.96万 - 项目类别:
Discovery Grants Program - Individual
Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration
VEGFA 在利用胆管细胞驱动的肝再生中的作用的研究
- 批准号:
10501501 - 财政年份:2022
- 资助金额:
$ 8.96万 - 项目类别: